Demographics of Lung Cancer in Females

Recruiting Observational Study
Lung Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Mansoura University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All female patients presented with bronchogenic carcinoma patients and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years. Exclusion Criteria: * lung metastasis ( not primary bronchogenic carcinoma)
Contacts

Mohamed AbdElmoniem

01014008473

dr.m1993@mans.edu.eg

CONTACT

Mohamed Mansour

01014008473

CONTACT